Bacitracin Zinc-polymyxin B Sulfate

   
Google
 
Web NewDrugInformation.com

Bacitracin Zinc-polymyxin B Sulfate


Drug - Bacitracin Zinc-polymyxin B Sulfate
The trade name of the product as shown on the labeling.

Dosage - OINTMENT; TOPICAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Bacitracin Zinc; Polymyxin B Sulfate
Multiple ingredients are in alphabetical order.

Strength - 500 UNITS/GM;10,000 UNITS/GM
The potency of the active ingredient(s), Bacitracin Zinc; Polymyxin B Sulfate. May repeat for multiple part products.

Applicant - NASKA
The firm name holding legal responsibility for Bacitracin Zinc-polymyxin B Sulfate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 062849
The FDA assigned number to Bacitracin Zinc-polymyxin B Sulfate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Bacitracin Zinc-polymyxin B Sulfate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Nov 13, 1987
The date Bacitracin Zinc-polymyxin B Sulfate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Bacitracin Zinc-polymyxin B Sulfate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Bacitracin Zinc-polymyxin B Sulfate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Naska Pharmacal Co Inc Div Rugby Darby Group Cosmetics
The full name of the firm holding legal responsibility for the new application of Bacitracin Zinc-polymyxin B Sulfate.

Bacitracin Zinc-polymyxin B Sulfate


Neosporin 400 Units/gm;eq 3.5mg Base/gm;10,000 Units/gm Ointment; Ophthalmic
Bacitracin Zinc-neomycin Sulfate-polymyxin B Sulfate 400 Units/gm;eq 3.5mg Base/gm;5,000 Units/gm Ointment; Topical
Polysporin 10,000 Units/gm;2,000,000 Units/gm Aerosol; Topical
Bacitracin Zinc And Polymyxin B Sulfate 500 Units/gm;10,000 Units/gm Ointment; Ophthalmic
Bacitracin Zinc And Polymyxin B Sulfate 500 Units/gm;10,000 Units/gm Ointment; Ophthalmic
Bacitracin Zinc And Polymyxin B Sulfate 500 Units/gm;10,000 Units/gm Ointment; Ophthalmic
Ocumycin 500 Units/gm;10,000 Units/gm Ointment; Ophthalmic
Polysporin 500 Units/gm;10,000 Units/gm Ointment; Ophthalmic
Bacitracin Zinc-polymyxin B Sulfate 500 Units/gm;10,000 Units/gm Ointment; Topical
Neo-polycin 500 Units/gm;eq 3.5mg Base/gm;10,000 Units/gm Ointment; Ophthalmic

NewDrugInformation